Crossmark

Development of institutional guidelines for menstrual suppression and abnormal uterine bleeding in patients undergoing intensive chemotherapy for hematologic malignancies

Crossref DOI link: https://doi.org/10.1007/s00520-025-10298-y

Published Online: 2026-01-05

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Roberts, Logan https://orcid.org/0009-0003-0830-0884
Stokvis, Kristin

Christianson, Mindy

Gojo, Ivana

Seraphin, Megan

Newman, Matthew
License Information

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2026-01-01
More Information

Article History

Received: 8 January 2025

Accepted: 24 December 2025

First Online: 5 January 2026

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of The Johns Hopkins Hospital.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below